More reads
- One biohacker’s improbable bid to make a DIY Covid-19 vaccine. (Bloomberg)
- Bristol Myers says Celgene buyout could supercharge sales to $20B. (FierceBiotech)
viernes, 26 de junio de 2020
Bristol Myers says Celgene buyout could supercharge sales to $20B | FierceBiotech
Bristol Myers says Celgene buyout could supercharge sales to $20B | FierceBiotech
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario